Citius Pharmaceuticals, Inc. (CTXR): Revenue
Older than the company's other figures. The latest Revenue is for the year ended 2022-09-30, while the company's latest annual report covers the year ended 2025-09-30. Its later filings do not report this line under the concept TickerFacts maps.
$90.0K
Year ended 2022-09-30
0.0%
3-year compound annual growth
+12.5%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2022-09-30 | $90.0K | 0.0% | 2022-12-22, From 2021-10-01 |
| 2021-09-30 | $90.0K | 0.0% | 2022-12-22, From 2020-10-01 |
| 2020-09-30 | $90.0K | 0.0% | 2021-12-15, From 2019-10-01 |
| 2019-09-30 | $90.0K | +20.0% | 2020-12-16, From 2018-10-01 |
| 2018-09-30 | $75.0K | +50.0% | 2019-12-16, From 2017-10-01 |
| 2017-09-30 | $50.0K | n/a | 2019-12-16, From 2016-10-01 |